West Nile Virus Seroprevalence and Cross-Neutralization in Sera from Eastern and Central Sudan

Abstract

Objectives:

In regions with co-existing flaviviruses, the diagnosis of previous West Nile virus (WNV) infections is challenging due to cross-reacting antibodies. The aim of the study was to determine the frequency of previous WNV infections in sera from three Sudanese states by excluding potentially dengue virus (DENV) and ZIKV cross-reacting sera and to determine the percentage of WNV cross-neutralizing sera from individuals with previous DENV infection.

Methods:

Serum samples from Kassala, North Kordofan, and Red Sea state were screened for antibodies against DENV by ELISA. Sera without DENV antibodies (N = 106) and a matched set of sera with DENV antibodies (N = 108) was selected. In all blood samples the frequency of WNV-neutralizing antibodies and the antibody titers were measured with microplate neutralization assays. DENV and Zika virus (ZIKV) microplate neutralization assays were performed with all WNV neutralizing sera of the DENV negative group.

Results:

A fraction of 30.2% of the DENV antibody negative sera neutralized WNV. The seroprevalence increased with age from 9.5% to 41.7%. Men and women were equally affected. The percentage of DENV positive sera that neutralized WNV was 83.3%. DENV positive sera had higher WNV neutralization titers than DENV negative sera.

Conclusions:

A significant fraction of the DENV antibody negative sera from three regions in Sudan showed serologic evidence of previous WNV infection. In comparison, the large majority of DENV antibody positive sera had WNV neutralizing antibodies. Studies are needed to identify clinical cases of WNV infection and to determine whether individuals with cross-neutralizing antibodies are protected from WNV disease.

Get full access to this article

View all access options for this article.

References

Adam

, Schüttoff

, Reiche

, et al. High seroprevalence of dengue virus indicates that dengue virus infections are frequent in central and eastern Sudan. Trop Med Int Health, 2018; 23(9):960–967; doi: 10.1111/tmi.13116.

Al Hag

, Enan

, Yassin

, et al. Prevalence of West Nile virus (WNV) among multiblood transfused patients in Khartoum State, Sudan. Int J Curr Res, 2014;6:8135–8139. Available at https://journalcra.com/sites/default/files/issue-pdf/6011.pdf (accessed August 1, 2022 ).

Gould

, Solomon

. Pathogenic flaviviruses. Lancet, 2008; 371:500–509; doi: 10.1016/S0140-6736(08)60238-X.

Hayes

, Sejvar

, Zaki

, et al. Virology, pathology, and clinical manifestations of West Nile virus disease. Emerg Infect Dis, 2005; 11:1174–1179; doi: 10.3201/eid1108.050289b.

Hogrefe

, Moore

, Lape-Nixon

, et al. Performance of Immunoglobulin G (IgG) and IgM enzyme-linked immunosorbent assays using a West Nile virus recombinant antigen (preM/E) for detection of West Nile virus- and other flavivirus-specific antibodies. J Clin Microbiol, 2004; 42:4641–4648; doi: 10.1128/JCM.42.10.4641-4648.2004.

McCarthy

, Haberberger

, Salib

, et al. Evaluation of arthropod-borne viruses and other infectious disease pathogens as the causes of febrile illnesses in the Khartoum Province of Sudan. J Med Virol, 1996; 48:141–146; doi: 10.1002/(SICI)1096-9071(199602)48:2<141::AID-JMV4>3.0.CO;2-9.

Musso

, Desprès

. Serological diagnosis of flavivirus-associated human infections. Diagnostics, 2020; 10:302; doi: 10.3390/diagnostics10050302.

Papa

, Karabaxoglou

, Kansouzidou

. Acute West Nile virus neuroinvasive infections: Cross-reactivity with dengue virus and tick-borne encephalitis virus. J Med Virol, 2011; 83:1861–1865; doi: 10.1002/jmv.22180.

Pierson

, Diamond

. The continued threat of emerging flaviviruses. Nat Microbiol, 2020; 5:796–812; doi: 10.1038/s41564-020-0714-0.

10.

Price

, Thind

. The mechanism of cross-protection afforded by dengue virus against West Nile virus in hamsters. J Hyg Camb, 1972; 70:611–617; doi: 10.1017/s0022172400022476.

11.

Rathore

APS

, St. John AL. Cross-reactive immunity among flaviviruses. Front Immunol, 2020; 11:334; doi: 10.3389/fimmu.2020.00334.

12.

Salim

, Porterfield

. A serological survey on arbovirus antibodies in the Sudan. Trans R Soc Trop Med Hyg, 1973; 67:206–210; doi: 10.1016/0035-9203(73)90145-4.

13.

Schüttoff

, Adam

, Reiche

, et al. Enhancing the concordance of two commercial dengue IgG ELISAs by exchange of the calibrator sample. J Clin Virol, 2019; 118:1–5; doi: 10.1016/j.jcv.2019.07.004.

14.

Smithburn

, Jacobs

. Neutralization-tests against neurotropic viruses with sera collected in Central Africa. J Immunol, 1942;44:9–23. Available at https://www.jimmunol.org/content/jimmunol/44/1/9.full.pdf (accessed August 1, 2022 ).

15.

Vázquez-Calvo

, Blázquez

A-B

, Escribano-Romero

, et al. Zika virus infection confers protection against West Nile virus challenge in mice. Emerg Micobe Infect, 2017; 6:e81; doi:10.1038/emi.2017.68

16.

Watts

, El-Tigani

, Botros

, et al. Arthropod-borne viral infections associated with a fever outbreak in the Northern Province of Sudan. J Trop Med Hyg, 1994;97:228–230. Available at https://apps.dtic.mil/dtic/tr/fulltext/u2/a285313.pdf (accessed August 1, 2022 ).

17.

Yousof

, Ahmed

, Noor

, et al. Seroprevalence of West Nile virus among blood donors at Central Blood Bank, Khartoum State, Sudan. Ann Med Biomed Sci, 2018;4:8–10. Available at http://ambs-journal.co.uk/articles/42AMBS%208-10%202018.pdf (accessed August 1, 2022 ).